Schechter Investment Advisors LLC cut its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 34.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,358 shares of the company's stock after selling 7,168 shares during the quarter. Schechter Investment Advisors LLC owned 0.09% of U.S. Physical Therapy worth $967,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in USPH. Envestnet Asset Management Inc. grew its holdings in U.S. Physical Therapy by 5.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company's stock worth $22,901,000 after acquiring an additional 16,698 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of U.S. Physical Therapy by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock worth $6,148,000 after purchasing an additional 1,873 shares during the period. Teacher Retirement System of Texas lifted its position in shares of U.S. Physical Therapy by 6.9% in the 1st quarter. Teacher Retirement System of Texas now owns 57,381 shares of the company's stock worth $4,152,000 after purchasing an additional 3,710 shares during the period. First Horizon Advisors Inc. lifted its position in shares of U.S. Physical Therapy by 35.0% in the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock worth $140,000 after purchasing an additional 500 shares during the period. Finally, Bessemer Group Inc. lifted its position in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after purchasing an additional 208 shares during the period.
Insider Buying and Selling
In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company's stock.
U.S. Physical Therapy Stock Up 2.0%
Shares of U.S. Physical Therapy stock traded up $1.46 during trading on Thursday, reaching $75.19. 135,029 shares of the company traded hands, compared to its average volume of 137,560. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The company has a 50 day moving average price of $76.75 and a 200-day moving average price of $78.73. The firm has a market capitalization of $1.14 billion, a PE ratio of 34.49, a P/E/G ratio of 3.55 and a beta of 1.44.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. U.S. Physical Therapy's quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.51 EPS. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a yield of 2.39%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. JMP Securities restated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Barrington Research restated an "outperform" rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Finally, Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.
Get Our Latest Stock Report on USPH
U.S. Physical Therapy Company Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.